A round-up of the latest expansion plans and new facilities as building fever grips the industry

Could existing drugs be repurposed as a shortcut to treating Ebola?

Big pharma is turning to outside sources to fill pipelines, but how often are companies backing the wrong horse?

Manufacturers must prove that new drug products are free of cancer-causing impurities

How did the NIH get it so wrong – and how can it move on?

Rising drug prices are not helping the industry’s image problem.

The biopharmaceutical sector is rapidly evolving – can your supply chain keep up?

Most pharma companies want to become more patient focused. But how? You could start by simply listening more carefully.

The feel of a topical formulation can make a big difference to compliance.

Pharmaceutical and regulatory professionals around the world must speak the same language.